Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

1215709-75-3Aceclofenac EP Impurity G

● Auf Lager

Katalog-Nr.::	VL284009
CAS-Nr.::	1215709-75-3
Summenformel::	C18H15Cl2NO6
Molare Masse::	412.22 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 1215709-75-3

Parent drug

Aceclofenac

IUPAC-Name

[[[[[2-[(2, 6-Dichlorophenyl)amino]phenyl] acetyl]oxy]acetyl]oxy]acetic acid

Pharmakopöe-Synonyme

Acetic Aceclofenac

Other Synonyms

Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, 2-(carboxymethoxy)-2-oxoethyl ester; 2-[2-[2-[2-(2,6-dichloroanilino)phenyl]acetyl]oxyacetyl]oxyacetic acid; 2-(2-(2-(2-(2,6-Dichlorophenylamino)-phenyl)acetoxy)acetoxy)acetic acid; Carboxymethyl Aceclofenac;

Smile

O=C(O)COC(COC(CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl)=O)=O

Beschreibung

Aceclofenac EP Impurity G (CAS No: 1215709-75-3) or [[[[[2-[(2,6-Dichlorophenyl)amino]phenyl] acetyl]oxy]acetyl]oxy]acetic acid is a process related impurity observed in Aceclofenac that reduces joint inflammation, pain intensity and the span of morning stiffness in patients suffering from rheumatoid arthritis

References

Karbhari, PradnyaA, et al. â€œRP-LC Gradient Elution Method for Simultaneous Determination of Thiocolchicoside, Aceclofenac and Related Impurities in Tablet Formulation.â€Â Journal of Pharmacy and Bioallied Sciences, vol. 6, no. 4, 2014, p. 246, https://doi.org/10.4103/0975-7406.142955. Dooley, Mukta, et al. â€œAceclofenac.â€ Drugs, vol. 61, no. 9, 2001, pp. 1351â€“78, https://doi.org/10.2165/00003495-200161090-00012. ?